PITCH 2014

Discover the Innovative Potential of the Sudbury Community!

Sudbury PITCH 2014

Introductions


The Pitches

Leak Prevention Ltd.

with Jeff Fuller

COMPANY OVERVIEW:
Originally designed as a wear advisor in rubber lined systems, the inventor and industrial designer, Dan Chamberland and entrepreneur Jeff Fuller, quickly recognized the larger potential for the technology and created a new venture. Initial sales into the mining industry along with strong interest from Enbridge and the oil / gas industry have encouraged the pair to seek the proper financing required to bring it to the larger market with proper funding and support have encouraged the pair to seek the proper financing required to bring it to the larger market with proper funding and support.


Verv Technologies

with Jeff Sutton

COMPANY OVERVIEW:

Verv Technologies is a small start-up focused on the $2.3B and growing worldwide PoC in-vitro (blood) diagnostic testing business. Until now many useful diagnostic tests have been unavailable in PoC settings because of the inability to separate plasma from whole blood. This is a major problem in the industry which Verv has solved. With their patent-pending technology, equipment manufacturers can now build truly portable plasma-based testing systems for all PoC settings.


Plan A Scheduling

with Sheri Tomchick

COMPANY OVERVIEW:
Plan A Scheduling Solutions has taken the timeless problem of filling “last minute” staffing requests and developed a solution that can access the right resources and fill positions within seconds. Their initial market focus is on the healthcare staffing industry – a big market with significant challenges and opportunities. In today’s world, it is unbelievable how much time we waste trying to schedule meetings, appointments, social events, and staffing – the latter being Plan A’s initial target market.


RNA Diagnostic

with John Connolly

COMPANY OVERVIEW:
RDA™ technology was licensed from Laurentian University in 2010. Clinical validation for the RNA Disruption Assay™ was established in a multi-centre breast cancer clinical trial. Broad patents covering the Company’s intellectual property are filed in multiple markets. The management team led by Dr. Ken Pritzker has extensive experience in medical diagnostics, diagnostic assay development and Medtech company management.